Related Experiment Video
Updated: May 6, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer
Akihiro Yamamura1, Koh Miura, Hideaki Karasawa
1Department of Surgery, Tohoku University, Graduate School of Medicine, Sendai, Japan; Department of Pathology, Tohoku University, Graduate School of Medicine, Sendai, Japan.
Abstract:
Pancreatic cancer is a highly lethal disease with a poor prognosis; the molecular mechanisms of the development of this disease have not yet been fully elucidated. N-myc downstream regulated gene 2 (NDRG2), one of the candidate tumor suppressor genes, is frequently downregulated in pancreatic cancer, but there has been little information regarding its expression in surgically resected pancreatic cancer specimens. We investigated an association between NDRG2 expression and prognosis in 69 primary resected pancreatic cancer specimens by immunohistochemistry and observed a significant association between poor prognosis and NDRG2-negative staining (P=0.038). Treatment with trichostatin A, a histone deacetylase inhibitor, predominantly up-regulated NDRG2 expression in the NDRG2 low-expressing cell lines (PANC-1, PCI-35, PK-45P, and AsPC-1). In contrast, no increased NDRG2 expression was observed after treatment with 5-aza-2' deoxycytidine, a DNA demethylating agent, and no hypermethylation was detected in either pancreatic cancer cell lines or surgically resected specimens by methylation specific PCR. Our present results suggest that (1) NDRG2 is functioning as one of the candidate tumor-suppressor genes in pancreatic carcinogenesis, (2) epigenetic mechanisms such as histone modifications play an essential role in NDRG2 silencing, and (3) the expression of NDRG2 is an independent prognostic factor in pancreatic cancer.
Insights
N-myc downstream regulated gene 2 (NDRG2) is downregulated in pancreatic cancer, correlating with poor prognosis. Histone modification, not DNA methylation, appears to silence NDRG2, suggesting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Pancreatic cancer is a lethal disease with poorly understood molecular mechanisms.
- N-myc downstream regulated gene 2 (NDRG2) is a potential tumor suppressor frequently downregulated in pancreatic cancer.
- Limited data exists on NDRG2 expression in resected pancreatic cancer tissues.
Purpose of the Study:
- To investigate the association between NDRG2 expression and prognosis in pancreatic cancer.
- To explore the role of epigenetic mechanisms, specifically DNA methylation and histone modification, in NDRG2 regulation.
- To determine if NDRG2 expression is an independent prognostic factor.
Main Methods:
- Immunohistochemistry was used to assess NDRG2 expression in 69 surgically resected pancreatic cancer specimens.
- Cell lines were treated with trichostatin A (histone deacetylase inhibitor) and 5-aza-2' deoxycytidine (DNA demethylating agent).
- Methylation-specific PCR was performed to detect hypermethylation in cell lines and tissues.
Main Results:
- NDRG2-negative staining was significantly associated with poor prognosis in pancreatic cancer patients (P=0.038).
- Trichostatin A upregulated NDRG2 expression in low-expressing cell lines, while 5-aza-2' deoxycytidine had no significant effect.
- No hypermethylation of NDRG2 was detected in pancreatic cancer cell lines or specimens.
Conclusions:
- NDRG2 functions as a tumor suppressor gene in pancreatic carcinogenesis.
- Epigenetic silencing of NDRG2 likely involves histone modifications rather than DNA methylation.
- NDRG2 expression serves as an independent prognostic factor for pancreatic cancer.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...